{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:23:36Z","timestamp":1766157816329},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T00:00:00Z","timestamp":1426464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0119801","type":"journal-article","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T18:20:34Z","timestamp":1426530034000},"page":"e0119801","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Arginine Depletion by Arginine Deiminase Does Not Affect Whole Protein Metabolism or Muscle Fractional Protein Synthesis Rate in Mice"],"prefix":"10.1371","volume":"10","author":[{"given":"Juan C.","family":"Marini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inka Cajo","family":"Didelija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,3,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"K Fearon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","article-title":"Muscle wasting in cancer","volume":"45","author":"N Johns","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.1993.126","article-title":"Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia","volume":"67","author":"KL Smith","year":"1993","journal-title":"Br J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<42::AID-CNCR5>3.0.CO;2-M","article-title":"Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover","volume":"82","author":"F Dworzak","year":"1998","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1074\/jbc.M610378200","article-title":"Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation","volume":"282","author":"HL Eley","year":"2007","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/jcmm.12165","article-title":"Motor protein function in skeletal abdominal muscle of cachectic cancer patients","volume":"18","author":"S Taskin","year":"2014","journal-title":"J Cell Mol Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbrc.2013.05.018","article-title":"Cancer cachexia decreases specific force and accelerates fatigue in limb muscle","volume":"435","author":"BM Roberts","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0884533612457949","article-title":"Importance of lean body mass in the oncologic patient","volume":"27","author":"S Tsai","year":"2012","journal-title":"Nutr Clin Pract"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1626S","DOI":"10.1093\/jn\/137.6.1626S","article-title":"Nutritional consequences of interspecies differences in arginine and lysine metabolism","volume":"137","author":"RO Ball","year":"2007","journal-title":"J Nutr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/jn\/138.5.867","article-title":"Dietary arginine supplementation increases mTOR signaling activity in skeletal muscle of neonatal pigs","volume":"138","author":"K Yao","year":"2008","journal-title":"J Nutr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jnutbio.2005.12.001","article-title":"Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates","volume":"17","author":"WS Jobgen","year":"2006","journal-title":"J Nutr Biochem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2791S","DOI":"10.1093\/jn\/134.10.2791S","article-title":"Renal arginine metabolism","volume":"134","author":"ME Brosnan","year":"2004","journal-title":"J Nutr"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1152\/ajplegacy.1973.224.1.127","article-title":"Relative importance of kidney and liver in synthesis of arginine by the rat","volume":"224","author":"WR Featherston","year":"1973","journal-title":"Am J Physiol"},{"key":"ref14","first-page":"F660","article-title":"Extrarenal citrulline disposal in mice with impaired renal function","volume":"307","author":"JC Marini","year":"2014","journal-title":"Am J Physiol"},{"key":"ref15","first-page":"1","article-title":"The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I\/II clinical trials","volume":"26","author":"A Synakiewicz","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.addr.2009.02.010","article-title":"PEG conjugates in clinical development or use as anticancer agents: An overview","volume":"61","author":"G Pasut","year":"2009","journal-title":"Adv Drug Deliver Rev"},{"key":"ref17","first-page":"1","article-title":"Enzymes of arginine and urea synthesis","volume":"39","author":"S Ratner","year":"1973","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj3630581","article-title":"Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor \u03b1 and endotoxin","volume":"363","author":"JB Thomas","year":"2002","journal-title":"Biochem J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2174\/138161208784246199","article-title":"Arginine deprivation as a targeted therapy for cancer","volume":"14","author":"L Feun","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10637-012-9862-2","article-title":"Phase I\/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma","volume":"31","author":"PA Ott","year":"2013","journal-title":"Invest New Drugs"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4143\/crt.2013.45.4.251","article-title":"Targeting arginine-dependent cancers with arginine-degrading enzymes: Opportunities and challenges","volume":"45","author":"M Phillips","year":"2013","journal-title":"Cancer Res Treat"},{"key":"ref22","first-page":"E69","article-title":"Glutamine: precursor or nitrogen donor for citrulline synthesis?","volume":"299","author":"JC Marini","year":"2010","journal-title":"Am J Physiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3945\/jn.111.153825","article-title":"Arginine and Ornithine Are the Main Precursors for Citrulline Synthesis in Mice","volume":"142","author":"JC Marini","year":"2012","journal-title":"J Nutr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/rcm.5007","article-title":"Quantitative analysis of <sup>15<\/sup>N-labeled positional isomers of glutamine and citrulline via electrospray ionization tandem mass spectrometry of their dansyl derivatives","volume":"25","author":"JC Marini","year":"2011","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1549S","DOI":"10.1093\/jn\/137.6.1549S","article-title":"An overview of phenylalanine and tyrosine kinetics in humans","volume":"137","author":"DE Matthews","year":"2007","journal-title":"J Nutr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"MJ Tisdale","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref27","first-page":"251","article-title":"Weight loss and nutritional abnormalities in cancer patients: Incidence, severity and significance","volume":"5","author":"WD DeWys","year":"1986","journal-title":"Clinics Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MCO.0000000000000075","article-title":"Ghrelin: From discovery to cancer cachexia therapy","volume":"17","author":"A Molfino","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5301\/NTM.2014.12105","article-title":"Pathophysiology of malnutrition and cachexia in cancer patients","volume":"32","author":"M Taus","year":"2014","journal-title":"Nutr Ther Metab"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00520-008-0403-7","article-title":"A randomized, double-blind, placebo-controlled trial of a \u03b2-hydroxyl \u03b2-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)","volume":"16","author":"L Berk","year":"2008","journal-title":"Support Care Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.nut.2013.05.004","article-title":"Influence of a nutritional intervention on dietary intake and quality of life in cancer patients: A randomized controlled trial","volume":"29","author":"A Uster","year":"2013","journal-title":"Nutrition"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge based human protein atlas","volume":"25","author":"M Uhlen","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref33","first-page":"R310","article-title":"BioFPS: an extensible and customizable portal for querying and organizing gene annotation resources","volume":"10","author":"C Wu","year":"2009","journal-title":"Genome Biol"},{"key":"ref34","first-page":"240","article-title":"Drug evaluation: ADI-PEG-20\u2014A PEGylated arginine deiminase for arginine-auxotrophic cancers","volume":"8","author":"LJ Shen","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1593\/tlo.11262","article-title":"Recombinant human arginase Toxicity in mice is reduced by citrulline supplementation","volume":"5","author":"JP Mauldin","year":"2012","journal-title":"Transl Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0021-9258(17)35003-2","article-title":"The conversion of citrulline to arginine (transimination) by tissue slices and homogenates","volume":"166","author":"PP Cohen","year":"1946","journal-title":"J Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0119801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T02:00:17Z","timestamp":1651543217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0119801"}},"subtitle":[],"editor":[{"given":"Zane","family":"Andrews","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,16]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0119801","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,16]]}}}